SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/18/08 CytRx Oncology Corp 8-K:5 6/16/08 1:10K RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 12K
FORM 8-K |
INNOVIVE PHARMACEUTICALS, INC. | ||
(Exact name of registrant as specified in its charter) |
Delaware | 000-51534 | 74-3123261 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) |
(IRS Employer ID Number) |
555 Madison Avenue, 25th Floor, New York, New York 10022 | ||
(Address of principal executive offices) (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
INNOVIVE PHARMACEUTICALS, INC. |
||||
Date: June 18, 2008 | /s/ Steven Kelly | |||
Steven Kelly | ||||
President and Chief Executive Officer | ||||
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/18/08 | None on these Dates | ||
For Period End: | 6/16/08 | |||
List all Filings |